Contraceptive Methods

  • mHealth

    Sophie Weiner

    CCP | Communications Specialist
    Tamunotonye Harry is a Nigerian-based digital health advocate who has completed several courses through K4Health’s Global Health eLearning platform.

    Tamunotonye Harry is a Nigerian-based digital health advocate who has completed several courses through K4Health’s Global Health eLearning platform. Photo Credit: Carrot Photography.

    Tamunotonye Harry is a young digital health professional based in Port Harcourt, Nigeria. After learning about the Global Health eLearning Center (GHeL) and taking a course on digital health, Tamunotonye connected with K4Health for information about our Global Digital Health Network. In this lightly edited interview, Tamunotonye explains how discovering GHeL has influenced his career path in a positive way.

    How did your experience in the National Youth Service Corps engage you in mHealth work?

    Tamunotonye Harry: I graduated from the University of Port Harcourt with a degree in Human Physiology in 2015. I had to wait a whole year before I was finally accepted into the National Youth Service Corps (NYSC). The one-year gap was actually a blessing as I used this time to gain work and volunteer experience, which involved building capacity for children with disabilities.

  • K4Health Highlights

    Lisa Mwaikambo

    CCP | Co-Manager, Global Health eLearning
    © 2004 Ahsanul Kabir, Courtesy of Photoshare

    A health worker administers a Somazet injection for family planning at a community health clinic in Islampur union, Rajbari district, Bangladesh. © 2004 Ahsanul Kabir, Courtesy of Photoshare

    Hormonal contraceptives are very effective in preventing pregnancy when used correctly and are an important part of a program's contraceptive method mix. There are many exciting developments in terms of new contraceptive technologies, as well as evidence that the renewed focus on long-acting reversible contraceptives (LARCs), specifically implants, has been quite successful in some countries. The following three come to mind:

    1.)    Injectable contraceptives continue to be one of the world’s most popular methods for preventing pregnancy, offering women safe and effective protection, convenience, and privacy. Until now, however, they have not been widely available outside clinic settings. The introduction of Sayana® Press, a lower-dose formulation and presentation of Depo-Provera®, offers the potential to improve contraceptive access for women worldwide.

    Sayana Press is a three-month, progestin-only injectable contraceptive product packaged in the Uniject™ injection system and administered via subcutaneous injection. It is small, light, easy to use, and requires minimal training, making it especially suitable for community-based distribution. PATH and partners are supporting country-led pilot introduction of Sayana Press in Bangladesh, Burkina Faso, Niger, Senegal, and Uganda, which will continue through 2016. 

  • Healthy Timing and Spacing of Pregnancy

    Leigh Wynne, MPH

    FHI 360 | Technical Advisor, Research Utilization

    This blog post originally appeared January 6, 2015 on The Pump, JSI's blog promoting and improving health. 

    In order to achieve FP2020’s goals and ensuring that people have access to a broad range of contraceptives, it is essential that the Standard Days Method® (SDM) be included as part of the family planning (FP) modern method mix in health facilities and community-based family planning (CBFP) programs. On December 9, 2014, Advancing Partners & Communities (APC) launched its series of CBFP related technical consultations. This consultation focused on raising awareness of SDM as part of the method mix. Close to 50 people representing over 20 different organizations, including representatives from USAID as well as country representatives of programs in India, Mali, Nigeria, Rwanda and Uganda, convened to discuss the integration of SDM into CBFP programs.

  • Integrating Family Planning and HIV Services

    Chelsea Polis

    Guttmacher Institute | Senior Research Associate

    Kavita Nanda

    FHI 360 | Senior Medical Scientist, Contraceptive Technology Innovation Department

    Chelsea Polis and Kavita Nanda were both directly involved in writing the two major documents mentioned: the 2014 WHO guidance and the USAID/PEPFAR briefer on HC-ART. 

    © 2013 Sarah V. Harlan/CCP, Courtesy of Photoshare

    A Health Extension Worker explains the systems she uses to keep track of her patients at the Saadamoo Health Post in the Oromia Region of Ethiopia. Health posts provide preventive care and treatment in a number of areas, including family planning and HIV. © 2013 Sarah V. Harlan/CCP, Courtesy of Photoshare

    Extraordinary gains have been made in the last decade towards increasing access to antiretroviral therapy (ART) for HIV. With an eye towards ending the AIDS epidemic by 2030, UNAIDS recently released bold targets related to HIV diagnosis and treatment. By the year 2020, their aim is to have 90% of all people living with HIV aware of their status, 90% of people diagnosed with HIV receiving sustained ART, and 90% of people on ART achieving viral suppression. As we move closer to these laudable public health goals, we must also consider how expansion of ART may affect and be affected by other health issues, such as prevention of unintended pregnancy among women living with HIV.

    Among all people living with HIV in low- and middle-income countries, 52% are women (57% in sub-Saharan Africa). Most are of reproductive age, and many may wish to use a hormonal contraceptive method to prevent unintended pregnancy, such as oral contraceptive pills, injectables, implants, or hormonal intrauterine devices (IUDs). Access to highly effective contraception has other health benefits as well; it reduces maternal and infant morbidity and mortality, and is a necessary component in ending mother-to-child HIV transmission.

  • Elizabeth Futrell

    (Formerly) CCP | Content Development Lead
    © 2008 Virginia Lamprecht, Courtesy of Photoshare

    A mother and her infant at a vasectomy clinic in Rwanda. © 2008 Virginia Lamprecht, Courtesy of Photoshare

    While tragic, the deaths of 13 women in India last week after undergoing female sterilization—possibly attributable to tainted medicine administered after surgery— were highly unusual. In fact, female sterilization is the most widely-used contraceptive method globally, and with good reason. As this  interactive data visualization tool from the New York Times demonstrates, female and male sterilization are among the safest, most effective, and most cost-efficient family planning methods for those who wish to permanently prevent or limit pregnancies. 

    As women have the children they want, if they decide on permanent contraception, they no longer have to spend that money every month or every three months for an injectable [contraceptive] or every three to five years for an implant. They can take on other things with the confidence they won't become pregnant. They can take on jobs and we know that women who have opportunities to do that often do relatively well and are able to contribute income to their families. They have a sense of autonomy, are less subjected to gender-based violence and overall, have a fuller, richer life. –John Townsend, Population Council

    Earlier this week, NPR aired an interview with John Townsend, Population Council’s Director of Reproductive Health, who discussed why so many families around the world rely on sterilization and what constitutes a safe environment for these procedures. Read or listen to the full interview.

    For more information about male and female sterilization, please visit K4Health's Permanent Methods Toolkit